Houston, TXNCT06271265Now EnrollingIRB Ready

Postoperative Pain Clinical Trial in Houston, TX

Access cutting-edge postoperative pain treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by Pacira Pharmaceuticals, Inc

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access postoperative pain specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related postoperative pain treatment provided free

Apply for This Houston Location

Check if you qualify for this postoperative pain clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Postoperative Pain Study in Houston

This Phase 1, multicenter, open-label, randomized, bupivacaine-controlled study is designed to evaluate the pharmacokinetics (PK) and safety of EXPAREL vs. bupivacaine HCl for postsurgical analgesia in pediatric subjects aged 0 to less than 6 years of age undergoing cardiac surgery, utilizing local infiltration analgesia (LIA).

Sponsor: Pacira Pharmaceuticals, Inc

Who Can Participate

Inclusion Criteria

All of the following inclusion criteria must be met for eligibility:
Pediatric participants with congenital heart defects planned to undergo cardiac surgery with cardiopulmonary bypass
Male or female participants from 0 to less than 6 years of age on the day of surgery: 2 years to less than 6 years of age for Part 1; 6 months to less than 2 years of age for Part 2; 0 to less than 6 months of age for Part 3
American Society of Anesthesiologists (ASA) Classes 1 through 4.
Parent/guardian is able to speak, read, and understand the language of the ICF and provide informed consent for the participant.
Parent/guardian is able to adhere to the study visit schedule and complete all study assessments for the participant.

Exclusion Criteria

History of hypersensitivity or idiosyncratic reactions or contradictions to EXPAREL, bupivacaine HCl, or other amide-type local anesthetics or to opioid medications
Administration of EXPAREL or bupivacaine HCl within 30 days prior to IP administration
Administration of an IP within 30 days or 5 elimination half-lives of such IP, whichever is longer, prior to IP administration, or planned administration of another IP or procedure during participation in this study
History of preterm birth (before 35 weeks of pregnancy)
History of coagulopathies or immunodeficiency disorders
Disease or condition that, in the opinion of the Investigator, indicates an increased vulnerability to IPs and/or procedures
Recent or potential exposure to COVID-19
Cardiac surgery has been canceled and cannot be rescheduled within 30 days of signing the ICF because of any reason.
Necessity in delayed wound closure
Informed consent withdrawn before randomization

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT06271265) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Postoperative Pain Treatment Options in Houston, TX

If you're searching for postoperative pain treatment options in Houston, TX, this clinical trial (NCT06271265) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced postoperative pain specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all postoperative pain clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Houston, TX

See all pulmonary embolism clinical trials recruiting in Houston — not just this study.

Browse Pulmonary Embolism Trials in Houston →

Browse More Trials by Condition

Pulmonary Embolism TrialsRheumatoid Arthritis TrialsPost-Surgical Pain TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX